• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CO2, gadolinium prove utility in uterine fibroids treatment

Article

Carbon dioxide and gadolinium are safe and effective contrast media for uterine artery embolization, according to a study from Johns Hopkins University. Their use provides an alternative for patients who are allergic to conventional iodinated contrast agents, and low doses reduce the risk of nephrogenic systemic fibrosis.

Carbon dioxide and gadolinium are safe and effective contrast media for uterine artery embolization, according to a study from Johns Hopkins University. Their use provides an alternative for patients who are allergic to conventional iodinated contrast agents, and low doses reduce the risk of nephrogenic systemic fibrosis.

Dr. Hyun S. Kim, an assistant professor of radiology at Hopkins, and colleagues evaluated the technique in eight patients with symptomatic fibroids. The patients underwent angiography after injection of about 30 to 40 mL of CO2 using a commercially available microcatheter system. They then received the embolization agent mixed with a low dose of the gadolinium-based contrast agent. This approach worked safely and effectively as contrast media in this group of patients, without major complications (J Vasc Interv Radiol 2007;18 [8]:1021-1027).

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.